This investigation forms part of a study of the secretory capacity of the rat's adrenal cortex after structural changes have been produced in the gland by the administration of drugs and hormones. The two examples to be discussed are the effects of hexoestrol' and of 'amphenone B' (1, 2-bis (p-aminophenyl)-2 methyl-propanone-1 dihydrochloride). The latter substance, subsequently to be called 'amphenone,' was generously supplied by Dr. R. Hertz.
This investigation forms part of a study of the secretory capacity of the rat's adrenal cortex after structural changes have been produced in the gland by the administration of drugs and hormones. The two examples to be discussed are the effects of hexoestrol' and of 'amphenone B' (1, 2-bis (p-aminophenyl)-2 methyl-propanone-1 dihydrochloride). The latter substance, subsequently to be called 'amphenone,' was generously supplied by Dr. R. Hertz.
The functional state of the glands was tested by collecting the venous effluent from the left adrenal gland during anaesthesia and then carrying out a chemical estimation of the corticosterone secreted; unlike other species, the rat does not produce cortisol,' even after intensive treatment with ACTH'; in this respect the rat differs from the rabbit which has been shown to secrete cortisol after prolonged administration of ACTH.' Since, again in contrast to the rabbit, the rat does not secrete dehydrocorticosterone either, corticosterone estimations are a reliable guide to the rat's secretion of 'glucocorticoids. ' The conditions of the experiments were those of operative stress, and the secretion was therefore approaching or equalling maximal secretory capacity of the gland. This is shown by the fact that infusion of ACTH during such an operation produces little further increase in hormone output. Information on 'resting secretion' is not afforded by this technique.
METHODS
Adult male rats weighing between 250 and 400 g were used. The pre-operative treatment consisted of either: (c) Four daily injections of hexoestrol as under (a), followed by at least four days in which treatments (a) and (b) were combined.
Estimation of corticosterone
The method' consisted of collecting blood from the left renal vein in a heparinized rat anaesthetized either with urethane (1.5 g/kg) or pentobarbital (45 mg/kg). Tributaries to the renal vein other than the adrenal vein were tied, and so was the entry of the renal vein into the vena cava. The right femoral vein was cannulated so that intravenous injections could be given, and the blood pressure was recorded from the right femoral artery whenever desirable.
The blood was centrifuged, the plasma extracted with organic solvents and the purified extract chromatographed on paper with one of Bush's8 solvent systems. Markers of pure steroids were run together with the extracts. After developing the chromatogram, the steroids were located by U.V. absorption, and the corticosterone was eluted with ethanol. The eluate was evaporated to dryness and the colour formed by the residue on incubation with blue tetrazolium measured in the spectro-photometer at 520 m,u (modification of the method of Mader and Buck'6). The possible occurrence of substances other than corticosterone was investigated by spraying developed chromatograms with a 12 per cent solution of NaOH in water containing 3 mg blue tetrazolium per 100 ml, drying the paper rapidly and examining the fluorescence in U.V. light.8
RESULTS

Hexoestrol
. It is well known that oestrogens in general, and stilboestrol and hexoestrol in particular, cause a rapid loss of lipids from the adrenal cortex'5"o; the effect is dependent on the integrity of the pituitary and persists for weeks provided treatment is maintained; only after many months may there be restitution of normal lipid content."'a The loss of lipids is accompanied by a variable hypertrophy of the gland and an increase in vascularity which may lead to hemorrhage; following oestradiol administration, increased amounts of ACTH are circulating in the blood. 6 The functional state of such adrenals has been a matter of much speculation, hyperactivity being stipulated by some, exhaustion following initial hyperactivity by others; a third view' suggested that the hypertrophy might be a secondary effect of excessive ACTH secretion, resulting from lack of hormone production by an inhibited adrenal cortex. This latter hypothesis would create an analogy between the action of thiouracil on the thyroid and that of oestrogens on the adrenal. Figure 1 represents the results of a group of experiments carried out in urethane anaesthesia (left part of the figure), and another group done under pentobarbital (right part). The secretion per min per g adrenal is shown in black columns, and the value per single adrenal per hr per kg body weight in white columns. After hexoestrol the secretion was severely depressed, both per g adrenal tissue and per kg body weight. Whereas the secretion of normal rats was the same with both anaesthetics, the depression by hexoestrol was more severe in urethane anaesthesia. In these experiments, the shortest treatment with hexoestrol lasted 3 Experiments were also carried out to see whether the diminished secretion of corticosterone was indicative of genuine depression of synthesis or whether another steroid was produced which might replace the normal compound. This was done by carrying out the NaOHfluorescence test on chromatograms of plasma from rats treated with hexoestrol; any steroids with an a,f3-unsaturated ketone group are shown up by this reaction.! Not only was there no new compound to be found in such chromatograms, but the decrease in secretion of corticosterone was accom-panied by a decreased production of the androgen normally found in rat adrenal blood.
Ways were then sought thesis exerted by hexoestrol.' In one type of experiment, the immediate effect of various infusions was tried (Fig. 2 ). Rats were injected with hexoestrol for periods of 4 or 5 days, and a first 15-minute sample of blood collected in the usual way from the left adrenal. Then 8 ml of different solutions were infused, 4 ml during the 10 minutes before, and 4 ml during the first 10 minutes of collecting a second 15-minute sample of adrenal blood. Sometimes collection of the preinfusion sample was omitted. When the solution infused was plasma from normal rats, corticosterone secretion per g adrenal reverted to normal figures (Fig. 2, column 3 Column 4: an infusion of 8 ml plasma from hexoestrol-pretreated rats (0.4 mg/kg for 5 days). Column 5: an infusion of 8 ml 5% bovine albumin. Column 6: amphenone (0.2 g/kg for 4 days by stomach tube), while hexoestrol injections were being continued.
plasma constituent from the blood of rats injected with hexoestrol as a possible cause of the functional deficiency of the adrenal cortex in these animals.
The possibility, however, existed that the beneficial effect of normal plasma was due to a mere dilution of the hexoestrol present in the tissues; this was ruled out by infusing another hexoestrol-free solution of about the same colloid-osmotic pressure as plasma, a 5 per cent solution of bovine albumin. Such infusions had the same effect on the blood pressure as had rat plasma, but were devoid of any restorative action on cortical secretion (Fig. 2, column 5 ). It may be concluded from these experiments that hexoestrol does not produce its inhibitory effect on cortical secretion by causing any profound damage to the enzyme systems of the cell, but by depriving the adrenal of some substance which can be supplied by a brief infusion of normal rat plasma.
In the search for the substance which is lacking in adrenals of rats given hexoestrol, cholesterol suggests itself as a possibility. When hexoestrol is administered, there is rapid loss from the cortex of sudanophilic material, of which cholesterol is a major component; depletion persists as long as the hexoestrol is given,18 in contrast to what happens after administration of ACTH or in prolonged stress, where there is usually only an initial fall followed by an accumulation of cholesterol. Plasma cholesterol is very low after hexoestrol administration, and a lack of this precursor of adrenal steroids in the blood would explain the beneficial effects of infusing normal plasma to hexoestrol-treated rats, and the lack of improvement when plasma from rats which have themselves had hexoestrol is given instead. According to this theory, the damaging action of hexoestrol on the rat adrenal is exerted through an interference with cholesterol synthesis, leading to a decrease in the available amount of a material necessary for steroid synthesis. Direct support for this interpretation was obtained by Boyd and McGuire' who demonstrated a decrease in cholesterol synthesis from C14-labelled acetate in liver slices of rats given hexoestrol for periods of 6-13 days.
Other effects of hexoestrol can now be interpreted as a result of the interference with cholesterol synthesis. There will be increased production of ACTH due to a lack of circulating corticosterone; this leads to hypertrophy and hyperplasia of the adrenal cortex, and to hypertrophy of the anterior lobe of the pituitary, if treatment is sufficiently prolonged. The condition would thus be analogous to the response of the thyroid when antithyroid drugs are administered.
An important question is whether this action of hexoestrol occurs in other species including man or is restricted to the rat. Experiments on cats and rabbits have shown that the cat is very intolerant to hexoestrol and reacts with liver damage to rather small doses; adrenal changes were not produced with doses compatible with survival.' The rabbit, however, tolerated large amounts of hexoestrol, but neither adrenal lipids, nor corticosterone and cortisol secretion measured in operative stress, were decreased. '2 In man, there is as yet no evidence that adrenal histology or secretion are affected, though influences of oestrogens on plasma cholesterol and its transport mechanisms have been reported."" lb It is also of some interest to prising, particularly in view of the fact that, in man, amphenone has been reportede to decrease the excretion of 17-hydroxycorticoids in the urine and the level of 17-hydroxycorticoids in the plasma. In these patients, however, treatment was never longer than two or five days, and therefore a series of experiments of short duration was carried out in the rat. Table 1 shows that the results were essentially the same as with the chronic treatment. After two days, adrenal size was already increased, secretion per g gland was on the upper limit of normal, and secretion per kg bodyweight significantly above normal. After four days, all these effects had progressed further, and even secretion per g gland had risen signifi- cantly above the normal range. From this material it cannot be decided whether there is actually a peak in the effects after a few days with some recovery towards normal if treatment is prolonged; it is more likely that the peak at four days was only accidental. Histologically, accumulation of lipids and hypertrophy are noticeable after two days and go on increasing as treatment is being continued. These experiments do not give any information on corticoid secretion in the unstressed state, but they show conclusively that the adrenal has a much greater secretory capacity during stress when the rat has been fed amphenone for 2 to 17 days than without that treatment.
Two groups of authors""had come to a similar conclusion by attempting to carry out tests of adrenal function in rats fed with amphenone. Though interpretation was difficult, the experiments suggested an increased rather than a decreased capacity for secretion in these animals.
Inhibition of steroid synthesis has been reported when amphenone is infused intravenously in the hypophysectomized dog8 or added to the perfusion fluid of calf adrenals." In the dogs, the response to an intravenous injection of ACTH was inhibited, and in the calves, synthesis of cortico-sterone, cortisone, and cortisol was depressed, irrespective of whether ACTH had been added to the perfusion fluid. In an attempt at finding out whether the species or the mode of administration was responsible for the different responses, amphenone was given intravenously to rats, one sample of blood being collected before and one after the infusion of amphenone. The dose was the same as that used in the hypophysectomized dogs.8 The results are summarised in Table 2 . In contrast to the experiments in which amphenone was fed, corticosterone secretion was reduced to about one-half by approximately 50 mg/kg intravenous amphenone. It thus appears that not the species but the mode of administration was responsible for the inhibition of steroid synthesis experienced in the one and the stimulation experienced in the other type of experiment. It is of some interest to note that the intravenous amphenone was very poorly tolerated by the rats, and that infusion of large volumes of 0.9 per cent NaCi solution was required to keep the rats alive and their blood pressure at a safe level. A fall in blood pressure is also reported by Thorn et al.' in a patient who was given amphenone by the mouth. Whether the inhibition following intravenous amphenone is only a result of overdosage was checked by repeating the experiments with smaller amounts. Four infusions were carried out, and the doses of amphenone used were 3.3, 5, 10, and 11 mg/kg. The blood pressure was kept steady by infusion of rat blood whenever required. Small decreases in secretion of between 10 per cent and 15 per cent were observed, changes which hardly exceed accidental variations. There did not appear to exist a dose range at which increased secretion, as seen in the feeding experiments, occurred.
Since the effects of hexoestrol on corticosterone production and lipid storage in the adrenal are the opposite of those of amphenone, an attempt was made to restore the secretory depression and lipid loss due to hexoestrol by administering amphenone. All rats were first given four injections of hexoestrol, a treatment of sufficient duration to cause loss of lipids from all cortical layers except the glomerulosa and severe depression of secretory capacity. The hexoestrol injections were then combined with daily oral doses of amphenone for periods ranging from 4-12 days (Table 3) . In all these rats, lipids were deposited in the fasciculata so that the glands would have appeared like normal glands, had it not been for the hypertrophy and for the enlarged blood vessels in the zona reticularis. Secretion was restored to normal in all rats in which the combined treatment did not exceed four days (see also column 6, Fig. 2 ), whereas longer duration of the combined treatment led to normal figures per g gland in four and subnormal figures in three rats. It is, however, obvious that even in those animals in which secretion per g adrenal did not attain normal figures, secretion per kg bodyweight was far above that of rats to which hexoestrol alone had been administered. A striking feature of the combined treatment with hexoestrol and amphenone was that it invariably produced jaundice, whereas jaundice was not observed in rats given either compound alone.
Any attempt at interpreting the mode of action of amphenone will have to take into consideration the effects of ACTH on adrenal secretory capacity and on cortical morphology. The release of ACTH by amphenone cannot, as with hexoestrol, be interpreted as due to low levels of circulating cortical hormone, but is probably a consequence of the toxicity of the compound. There can, however, be no doubt about its release; it is suggested by the hypertrophy of the gland, its increase in vascularity and the demonstration by Hertz and Tullner9 that hypophysectomized, ACTH-maintained rats do not exhibit adrenal changes when fed with amphenone.
On comparing the effects of four days' feeding with amphenone and four days' injections of ACTH' (12 hourly injections of 1 u. Cortrophin Z, Organon, a 'delayed action-ACTH,' subcutaneously), lipid accumulation was found to be about the same, whether ACTH or amphenone had been given. When treatment was prolonged, lipid deposition became more excessive with amphenone than with ACTH. In the experiments which lasted four days, ACTH caused an increase in corticosterone secretion (per kg bodyweight) of approximately 50 per cent, whereas amphenone caused an increase of 150 per cent. Since, in such short experiments, changes in dosage and timing of the ACTH injections did not appear to increase the secretory performance any further, one might suspect an effect of amphenone on adrenal metabolism in addition to its capacity of releasing ACTH. In vitro effects have so far only been described as inhibitory,"'7 but the possibility that smaller doses might stimulate some phase of synthesis has not yet been explored.
SUMMARY
Adrenal secretory capacity was measured in rats by estimating the corticosterone secreted by the left adrenal during operative stress after the production of lipid depletion by hexoestrol and of lipid accumulation by amphenone.
Hexoestrol (0.4 mg/kg subcutaneously) inhibits corticosterone secretion, and this effect begins after as short an administration as two days and persists as long as hexoestrol is given. It is completely reversible by:
(a) Stopping the treatment (b) An intravenous infusion of normal rat plasma (c) Giving amphenone (0.2 g/kg by mouth) along with the hexoestrol. Procedures (a) and (c) bring the lipid deposition in the adrenal cortex back to normal.
When amphenone is administered (0.2 g/kg by mouth) for 2-17 days, the secretion of corticosterone per g gland is at the upper reaches of or above normal; secretion per gland is greatly enhanced. Large doses infused into the femoral vein inhibit secretion. The site of action of amphenone is discussed.
